{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:42:48Z","timestamp":1792212168681,"version":"4.4.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.2169\/internalmedicine.6646-25","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:10:35Z","timestamp":1772489435000},"page":"2658-2665","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and Safety of Immunosuppressive Therapy in Recurrent Autoimmune Pancreatitis"],"prefix":"10.2169","volume":"65","author":[{"given":"Yusuke","family":"Kurita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Medicine, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Tanida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Machida Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol 55: 462-470, 2020.","DOI":"10.1007\/s00535-019-01658-7"},{"key":"2","unstructured":"2. Okazaki K, Kawa S, Kamisawa T, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020. J Gastroenterol 57: 225-245, 2022."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 62: 1771-1776, 2013.","DOI":"10.1136\/gutjnl-2012-303617"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Masaki Y, Nakase H, Tsuji Y, et al. The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis. J Gastroenterol 56: 869-880, 2021.","DOI":"10.1007\/s00535-021-01817-9"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54: 1121-1125, 2005.","DOI":"10.1136\/gut.2004.049460"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Subramaniam K, D'Rozario J, Pavli P. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol 28: 24-30, 2013.","DOI":"10.1111\/jgh.12015"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40: 352-358, 2011.","DOI":"10.1097\/MPA.0b013e3182142fd2"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 58: 1504-1507, 2009.","DOI":"10.1136\/gut.2008.172908"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 56: 1719-1724, 2007.","DOI":"10.1136\/gut.2006.115246"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis\/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 7: 1089-1096, 2009.","DOI":"10.1016\/j.cgh.2009.03.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takahashi A, Arinaga-Hino T, Ohira H, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol 52: 631-640, 2017.","DOI":"10.1007\/s00535-016-1267-0"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62: 1607-1615, 2013.","DOI":"10.1136\/gutjnl-2012-302886"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. de Pretis N, Amodio A, Bernardoni L, et al. Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis. Clin Transl Gastroenterol 8: e90, 2017.","DOI":"10.1038\/ctg.2017.17"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 106: 151-156, 2011.","DOI":"10.1038\/ajg.2010.314"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xin L, Meng QQ, Hu LH, et al. Prediction and management for relapse of type 1 autoimmune pancreatitis after initial steroid treatment: a long-term follow-up from china. Pancreas 47: 1110-1114, 2018.","DOI":"10.1097\/MPA.0000000000001147"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 109: 1675-1683, 2014.","DOI":"10.1038\/ajg.2014.223"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rana SS, Gupta R, Nada R, et al. Clinical profile and treatment outcomes in autoimmune pancreatitis: a report from North India. Ann Gastroenterol 31: 506-512, 2018.","DOI":"10.20524\/aog.2018.0267"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wilson A, Jansen LE, Rose RV, et al. HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 47: 615-620, 2018.","DOI":"10.1111\/apt.14483"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 108: 610-617, 2013.","DOI":"10.1038\/ajg.2012.465"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Takikawa T, Kikuta K, Sano T, et al. Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: a multicenter cohort study in Japan. Pancreatology 24: 335-342, 2024.","DOI":"10.1016\/j.pan.2024.01.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kurita Y, Kubota K, Fujita Y, et al. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: a multicenter cohort study. J Hepatobiliary Pancreat Sci 31: 173-182, 2024.","DOI":"10.1002\/jhbp.1404"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/20\/65_6646-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:16:35Z","timestamp":1792210595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/20\/65_6646-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":21,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6646-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"article-number":"6646-25"}}